Last update 09 Nov 2024
LIT-00814
Last update 09 Nov 2024
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms LIT 00814, LIT-00814, LIT00814 |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with LIT-00814A Multicenter, Open Phase I Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-tumor Activity of LIT-00814 Tablets in Patients With Advanced Solid Tumor/Esophageal Cancer.
评价LIT-00814片在晚期实体瘤/食管癌受试者中的安全性、耐受性、药代动力学及初步抗肿瘤活性的多中心、开放性I期临床试验
[Translation] A multicenter, open-label Phase I clinical trial to evaluate the safety, tolerability, pharmacokinetics and preliminary anti-tumor activity of LIT-00814 tablets in subjects with advanced solid tumors/esophageal cancer
100 Clinical Results associated with LIT-00814
Login to view more data
100 Translational Medicine associated with LIT-00814
Login to view more data
100 Patents (Medical) associated with LIT-00814
Login to view more data
100 Deals associated with LIT-00814
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced Malignant Solid Neoplasm | Phase 1 | CN | 10 Oct 2023 | |
| Esophageal Carcinoma | Phase 1 | CN | 10 Oct 2023 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free